All In Biotech

Free tool

FAERS Monitor: Monistat 1 Combination Pack

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021308 or its brand name (Monistat 1 Combination Pack, Miconazole Nitrate). Reports on generic versions are filed under their own applications.

Reports

3,860

Serious

847

22% of reports

Hospitalization

337

Death reported

89

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vulvovaginal burning sensation1,168
  • drug ineffective737
  • vulvovaginal pain685
  • vulvovaginal pruritus388
  • condition aggravated369
  • vulvovaginal discomfort321
  • vaginal haemorrhage290
  • vulvovaginal swelling223
  • pain111
  • hypersensitivity100
  • vaginal discharge94
  • pruritus87
  • abdominal pain86
  • burning sensation85
  • off label use83

Reports by year received

View as table
YearReports
200414
200520
200622
200713
200837
200966
201046
201146
201275
201318
201427
201535
2016290
2017292
2018336
2019325
2020326
2021373
2022306
2023223
2024296
2025350
2026324

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,299 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
vulvovaginal burning sensationSignal1,1681288.91219.41,215,053
vulvovaginal painSignal685903.0838.2528,843
vulvovaginal swellingSignal223757.7661.0147,313
vulvovaginal pruritusSignal388451.9409.5160,836
vulvovaginal discomfortSignal321426.7382.5126,055
vaginal dischargeSignal9451.141.84,524
vaginal haemorrhageSignal29036.632.89,972
condition aggravatedSignal3696.66.01,779
burning sensationSignal856.65.4400
drug ineffectiveSignal7373.02.91,079
hypersensitivitySignal1002.92.4127
abdominal painSignal862.01.643
pruritus871.21.04
pain1111.00.80
off label use830.50.439

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.